| Literature DB >> 18053773 |
Abstract
India is getting to be known as a hot destination for executing clinical trials. It is witnessing the frenzied entry of pharma sponsor companies and contract research organizations and the movement of Indian non-healthcare groups into clinical research. In this mad melee, what are the determinants of success? How real is the promise of clinical research in India and what will make or break a new entrant in this business? This article attempts to describe these challenges and focuses on the resilient success criteria that the contract clinical research industry in India has tested every newcomer against.Mesh:
Year: 2007 PMID: 18053773 DOI: 10.1016/j.cct.2007.10.006
Source DB: PubMed Journal: Contemp Clin Trials ISSN: 1551-7144 Impact factor: 2.226